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Abstract Increases in 1H nuclear magnetic resonance
spectroscopy (NMR) visible lipids are a well-documented
sign of treatment response in cancers. Lipids in cytoplasmic
lipid droplets (LDs) are the main contributors to the NMR
lipid signals. Two human primitive neuroectodermal tumour
cell lines with different sensitivities to cisplatin treatment
were studied. Increases in NMR visible saturated and
unsaturated lipids in cisplatin treated DAOY cells were
associated with the accumulation of LDs prior to DNA
fragmentation due to apoptosis. An increase in unsaturated
fatty acids (UFAs) was detected in isolated LDs from DAOY
cells, in contrast to a slight decrease in UFAs in lipid extracts
from whole cells. Oleic acid and linoleic acid were identified
as the accumulating UFAs in LDs by heteronuclear single
quantum coherence spectroscopy (HSQC). 1H NMR lipids in
non-responding PFSK-1 cells were unchanged by exposure
to 10 lM cisplatin. These findings support the potential of
NMR detectable UFAs to serve as a non-invasive marker of
tumour cell response to treatment.
Keywords Lipid droplets  1H NMR  Isolation 
Cisplatin
1 Introduction
An increase in lipids detected by 1H NMR has been reported
in successful treatment of brain tumours (Griffin et al. 2003;
Hakumaki et al. 1999), lymphomas (Schmitz et al. 2005) and
breast cancers (Musacchio et al. 2009) indicating their
potential as non-invasive biomarkers in cancer management.
Studies on cancer cells in vitro (Shih et al. 2005) and in
preclinical tumour models (Griffin et al. 2003) have dem-
onstrated that apoptosis induced by anti-cancer therapies
results in subtle increases in saturated aliphatic 1H NMR
signals as well as unsaturated bis-allylic and vinyl peaks. The
increase in 1H NMR lipids is closely associated with an
increase in size and number of cytoplasmic lipid droplets
(LDs) (Mirbahai et al. 2012), the principal source of NMR
detectable lipids in vivo (Quintero et al. 2007). While some
cells show an increase in the CH2/CH3 ratio during apoptosis,
which could reflect an increase in the proportion of long
chain fatty acyl moieties (Shih et al. 2005), other cell lines
show no change in this ratio with treatment (Schmitz et al.
2005). Contributions to the –CH3 resonance from macro-
molecules rather than an increase in fatty acid chain length
can explain the increased CH2/CH3 ratio (Mirbahai et al.
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2012) but this has not been demonstrated directly in lipid
droplets. It has been proposed that NMR visible lipids
accumulating during apoptosis originate from membranous
cell structures due to lipolysis and repartitioning (Griffin
et al. 2003). However, a recent cell study concluded that de
novo lipid synthesis may also contribute to the accumulation
of 1H NMR lipid signals (Boren and Brindle 2012).
We have recently reported that lipids in LDs from
neuroblastoma cells contain phospholipids, triglyceride,
cholesterol and cholesteryl esters with both saturated and
unsaturated fatty acid chains being present (Pan et al.
2012). In the current study, two human primitive neuro-
ectodermal tumour (PNET) cell lines were treated with
cisplatin to examine lipid species in whole cells as well as
in extracts from whole cell and isolated LD preparations.
1D 1H NMR and 2D HSQC were used to characterise the
chemical nature of lipid species in untreated and cisplatin
treated cancer cells. Our hypothesis was that during cell
death, more unsaturated fatty acids would be observed in
the 1H NMR spectra of whole cells and that this would be
reflected in the composition of the isolated lipid droplets.
Information on the chemical nature of lipids in LDs will
help to improve our understanding of these important
structures and how they alter in the cell death process.
2 Materials and methods
2.1 Cell culture
Two neuronal brain tumour cell lines: DAOY, human
medulloblastoma and PFSK-1, human supratentorial primi-
tive neuroectodermal tumour were cultured in 75 cm2
flasks with filter-vented caps and maintained in 15 ml
Dulbecco’s modified eagles medium (DMEM F:12)
(Invitrogen, UK) supplemented with 10 % (v/v) foetal calf
serum (PAA, UK), 1 % 200 mM L-glutamine (1009) and
1 % non-essential amino acid solution (1009) (Sigma,
UK). Cells were incubated at 37 C in a humidified
atmosphere (5 % CO2, 95 % air).
2.2 Cisplatin exposure
2 mM stock solution was made from cisplatin powder
(Sigma Aldrich, UK) with DMEM stored at -80 C in
dark conditions. 10–100 lM cisplatin working solution
was freshly made from the stock cisplatin with culture
media before adding to the cell culture.
2.3 Alamar blue assay for cell viability
Cells were seeded in flat-bottomed IWAKI 96-well culture
plates at a density of 1 9 104cells/well and cultured for
24 h giving a 50–70 % confluence. Cisplatin was added
into each well and the plates were incubated at 37 C and
5 % CO2 for 48 h. Alamar blue assay to estimate number
of viable cells was performed as previously described (6).
2.4 Isolation of LDs
A protocol developed by Weller et al. was used to isolate
lipid droplets (Weller et al. 1991). Briefly, 40–60 9 106
cells were ground in 600 ll deionised water or D2O using a
Dounce grinder and the homogenate was centrifuged at
20009g at 4 C for 10 min. The supernatant was adjusted
to 18.46 % sucrose, topped with the same volume of
deionised water or D2O and centrifuged at 142,0009g for
120 min at 4 C (Optima TLX Ultracentrifuge, Beckman).
After ultracentrifugation, the sample was separated into
three fractions, the upper isolated fraction, the middle
sucrose fraction and the pellet. At least three independent
preparations for each condition and cell type were used for
isolation.
2.5 Lipid extraction
A dual-phase methanol–chloroform extraction protocol
was used to prepare the lipid extracts for NMR analysis
from both cells and isolated lipid droplets. 20–40 9 106
cells were ground and sonicated in methanol/deionised
water. 200 ll chloroform was added to the homogenates
twice to form a dual-phase. For isolated LDs, methanol and
chloroform was added directly into the isolated fraction. At
least three independent preparations from each condition
and cell type were used for extraction.
2.6 Nile red and DAPI staining
Cells were spun onto slides and stained with 4 lg/ml Nile
red, a dye staining for lipid droplets, in phosphate buffered
saline (PBS, made from 1 mg/ml Nile red stock solution in
acetone, Sigma Aldrich, Dorset, UK) for about 15 min
under dark conditions. After Nile red staining, cells were
stained with 0.4 lg/ml DAPI, a dye staining for cell nuclei,
for 15 min. 5 ll isolated fraction were dropped on to an
ethanol and deionised water washed slide and stained with
4 lg/ml Nile red in 70 % ethanol for 15 min. The slides
were visualized with a Nikon Eclipse E600 microscope and
images were taken using a DXM1200 digital camera. The
green fluorescence of Nile red was observed with FITC (B–
2A) filter set, with excitation wave length of 465–495 nm
and emission wave length of 550 nm. LD sizes were
measured using the image analysis software Image J
(National Institute of Health, USA). DAPI UV (UV–2A)
filter with excitation wavelength of 340–380 nm was used
to detect DAPI stained nuclei.
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2.7 HR-MAS
Prior to HR-MAS, frozen cells in PBS were defrosted, and
45 lL of suspension containing approximately 10 9 106
cells was pipetted into a 50 lL rotor (Bruker, Karlsruhe,
Germany); 5 lL 50 mmol/L trimethylsilylproprionate d4
(TMS) in D2O was added as a chemical shift standard. HR-
MAS was performed on a Bruker 500 MHz spectrometer
using a HR-MAS probe (Bruker, Karlsruhe, Germany). The
probe temperature was set to 278 K to minimize the deg-
radation. The rotor speed was 4,800 Hz in all experiments.
The pulse sequence consisted of a single 90 pulse with one
second water presaturation pulse. The receiver bandwidth
was 7,200 Hz covered with 16 K complex points. A
total of 256 scans were acquired with a repetition time of
3.3 s.
2.8 Liquid-state 1H NMR spectroscopy
Lipid extracts were resuspended in 600 ll deuterated
chloroform containing 0.03 % (v/v) TMS (Sigma Aldrich,
Dorset, UK). 1H NMR spectra of cell extracts and the
isolated LDs suspended in D2O were recorded on a Varian
600 MHz vertical bore spectrometer using a triple-reso-
nance HCN probe. A standard pulse-acquire sequence was
used as above for HR-MAS.
2.9 HSQC
A phase-sensitive gradient enhanced 2D 1H–13C HSQC
was performed on whole cell pellets of DAOY cells s on a
Bruker DRX 500 MHz spectrometers using the HR-MAS
probe at 278 K. 1,024 points were acquired in F2 for 256
increments in F1 with spectral widths of 13 and 166 ppm
respectively. 96 averages were performed resulting in a
total experiment time of approximately 11.6 h. Data were
zero-filled to twice the original length and multiplied by a
sine function prior to 2D Fourier transformation. Three
independent cell samples were used for HSQC experiment.
2.10 Spectral analysis
The HR-MAS spectra were manually phased and refer-
enced to creatine (3.03 ppm). Baseline correction (Xi and
Rocke 2008) was performed and spectra were normalized
to the total intensity of the spectral region from 0.5 to
4.5 ppm using in house software written in R. The signal
intensity of the lipid peaks around 0.9, 1.3, 2.8, 5.4 ppm
and the macromolecular peak at 1.68 ppm were measured
using peak integration to estimate the relative abundance of
lipid and macromolecule. Values shown are mean ± SD.
For extracts, the spectra were manually phased, then
referenced to TMS (0 ppm). The extract spectra were
baseline corrected with spectral analysis software, wxNUTs
(Acorn NMR Ltd, Canada). The lipid signal intensities were
determined using the line fitting function provided by
wxNUTs which fits a series of peaks to the experimental
spectrum and determines the signal intensity from the fit.
Student’s t test was performed on the treated versus
untreated cell data.
The HSQC spectra were manually phased, referenced to
TMS peak at 0 ppm and integrated with Topspin 3.0
software (Bruker, Germany).
3 Results
The Alamar blue assay showed that with a 48 h exposure to
10 lM cisplatin, 5 ± 0.2 % of DAOY cells were viable
while around 60 ± 1.1 % of PFSK-1 cells were still viable.
DAOY showed a clear response to 10 lM cisplatin,
whereas PFSK-1 did not. Thus, because of the discrimi-
nation, this concentration with a 48 h exposure time was
chosen for subsequent experiments.
Figure 1 shows the HR-MAS spectra of DAOY cells
treated with cisplatin, the spectra were scaled to the height of
the macromolecule peak at 1.68 ppm for display. For quan-
tification, the lipid signal intensities were taken as a ratio to
the macromolecule peak area at 1.68 ppm as referencing to
protein signal has been shown to be a good approach in NMR
signal quantification (Bayet-Robert et al. 2010) and renders
the data from different cell lines comparable.
Lipid signal intensities in HR-MAS spectra of DAOY
and PFSK-1 cells, as a function of cisplatin exposure times,
are shown in Fig. 2. In DAOY cells, the signals at 0.9, 1.3,
2.8 and 5.4 ppm start to increase by 24 h and continue to
increase with further treatment to 48 h. In PFSK-1 no
change in 1H NMR lipid peaks was detected.
Figure 3a shows 1H NMR spectra of lipid species in
extracts from isolated LDs following cisplatin treatment of
DAOY cells. For comparison, Fig. 3b shows the 1H NMR
spectra of lipid species in extracts from whole DAOY cells
following cisplatin treatment. The spectra over the range
1–5 ppm in Fig. 3a, b are scaled to give the same intensity
of the CH3 resonance. An expansion of the 5.35 ppm and
1.25–1.35 ppm regions is provided to show the increase of
CH=CH and –CH2 signal (arrows in Fig. 3a) from unsat-
urated lipids. For each expanded region, the intensity of the
spectra has also been increased by the same arbitrary factor
for all time points in order for them to be large enough to
appreciate the differences in intensity within a time series.
The fitting of the spectral region containing the CH3 res-
onance is shown in Fig. 3c.
Quantification of the 1H NMR spectra acquired from
lipid extracts showed that there was a statistically signifi-
cant increase in the CH=CH/CH3 ratio in lipids in LDs
724 X. Pan et al.
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from cisplatin treated DAOY cells (Fig. 4). No such
change was observed in LDs from PFSK-1 (Fig. 4). In
whole cell lipid extracts, the CH2/CH3 and CH=CH/CH3
ratios remained unchanged by treatment for both cell lines,
the apparent decrease in the DAOY cell line was not sta-
tistically significant. One should note that in untreated
DAOY cells the ratio of CH=CH/CH3 of LD lipids was
much lower than in PFSK-1, possibly due to inherent
properties of the cell types, but these ratios were similar in
lipids extracted from whole cells (including membrane
associated lipids as well as lipid droplets).
The HSQC (1H and 13C) spectrum acquired from 48 h
cisplatin treated DAOY cells is shown in Fig. 5. The chemical
nature of unsaturated lipids is of special interest (Griffin et al.
2003; Pan et al. 2012) but cannot be determined specifically
from the 1D NMR spectra. The double bond protons of
unsaturated fatty acids resonating at 5.4 ppm region in the 1D
spectra were separated into two distinguishable signals by the
2D HSQC assigned to oleic (18:1) and linoleic acid (18:2)
(Pan et al. 2012). The double bond protons in linoleic acid
give two signals with an equal intensity at the 5.4 ppm
making it possible to estimate the ratio of these two unsatu-
rated fatty acids. An oleic-to-linoleic acid ratio was found to
be 1:0.89 in cisplatin treated DAOY cells.
LDs are visualised as green vesicles in Nile red stained
cells, while cell nuclei stained with DAPI appear blue
(Fig. 6). There was an increase in the number of small LDs
(approximate diameter of 0.2 lm) by 12 h of 10 lM cis-
platin treatment in DAOY cells, while nuclei remained
intact, with a diameter around 15–20 lm. A ring-like
arrangement of small LDs was evident in DAOY cells
when the LD size increased by 24 h of cisplatin treatment.
After 48 h treatment, large LDs were seen with concomi-
tant fragmentation of nuclei. The average diameter of LDs
of 0.18 ± 0.06 lm in untreated DAOY cells remained
unchanged until 24 h of cisplatin exposure, but it had
increased to 0.34 ± 0.19 lm by 48 h (P \ 0.001 Student
t test). There was no change in either the number or the size
of LDs in PFSK-1 cells exposed to 10 lM cisplatin, similar
to untreated DAOY cells.
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Fig. 1 HR-MAS spectra of
DAOY (a) and PFSK-1(b) cells
treated with 10 lM cisplatin at
0, 12, 24 and 48 h. Assignments
are as follows: 1 CH3 at
0.9 ppm, 2 CH2 at 1.2–1.3 ppm,
3 CH2CH2CO at 1.6 ppm, 4
CH2CH=CH at 2.0 ppm, 5
CH2COO at 2.3 ppm,
6=CHCH2CH= at 2.8 ppm,
7 N(CH3)3 at 3.3–3.4 ppm, 8
HC=CH (L, Ch) at 5.4 ppm
Fig. 2 Lipid signal intensity of
lipid peaks at 0.9, 1.3, 2.8,
5.4 ppm of DAOY and PFSK-1
cells with or without 10 lM
cisplatin exposure. Values were
obtained from HR-MAS spectra
of intact cells
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Fig. 3 1H NMR spectra of lipid
extracts from a isolated LDs of
DAOY cells and b whole
DAOY cells treated with 10 lM
cisplatin at 0, 24 and 48 h. The
spectra are scaled such that the
CH3 triplet is the same intensity.
Assignments are as follows: 1
CH3 at 0.9 ppm, 2 CH2 at
1.2–1.3 ppm, 3 HC=CH (L, Ch)
at 5.4 ppm. To the right is the
5.4 ppm region and 1.3 ppm
region expanded to show the
lipid signal from HC=CH and
CH2 (indicated by arrows),
respectively. The intensities of
these peaks have been increased
by the same arbitrary factor for
all timepoints. (c): Line fit for
the –CH3 triplet (labelled as 1, 2
and 3) signal at 0.9 ppm
Fig. 4 Double bond proton signal/methyl group proton signal (CH=CH/CH3) and methylene group proton signal/methyl group proton signal
(CH2/CH3) from LD lipids and whole cell (WC) lipids of DAOY and PFSK-1 cell extract spectra
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4 Discussion
The current study shows that unsaturated fatty acids
detected by HR-MAS increase in whole DAOY cells
undergoing cisplatin-induced cell death, consistent with
studies on a glial tumour (Hakumaki et al. 1999) and
lymphoma cells (Schmitz et al. 2005). Extracts of LDs
show an increase in unsaturated fatty acids which reflect
those seen in HR-MAS of whole DAOY cells undergoing
apoptosis consistent with the 1H NMR signal arising from
the lipids pool present in LDs. The latter observation is
in agreement with previous cell (Quintero et al. 2007;
Zietkowski et al. 2012) and brain tumour (Griffin et al.
2003; Hakumaki et al. 1999) studies. These changes in
lipid composition are not detected in lipid extracts from
whole cells showing that the lipids from non-LD sources
(such as membranes) dilute observations from a specific
pool of 1H NMR visible species. It was recently shown that
apoptosis in EL4 lymphoma cells is accompanied with
increased incorporation of external oleate into triacylgly-
cerols (Boren and Brindle 2012). Considering the ratio of
oleic-to-linoleic acid in LDs from cisplatin treated DAOY
cells, it is possible that increase in unsaturation can be
ascribed to excessive accumulation of linoleic acid and its
incorporation into triacylglycerols. Two mechanisms have
been proposed to contribute to the increased unsaturated 1H
Fig. 5 HSQC spectra of 48 h
10 lM cisplatin treated DAOY
a whole spectrum from 0 to
6 ppm (1H) and 0 to 140 ppm
(13C), b expanded 5.44 to
5.35 ppm region of the
spectrum
Fig. 6 Combined Nile red and DAPI staining of DAOY (upper) and PFSK-1 (lower): a untreated cells at 0 h, b 10 lM cisplatin 24 h, c 10 lM
cisplatin 48 h. The size bar is 5 lm
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NMR detectable lipids in apoptotic cells: (a) repartitioning
from the cellular membrane degradation (Griffin et al.
2003) and (b) de novo synthesis of lipids. (Boren and
Brindle 2012; Zietkowski et al. 2012).
Cisplatin as a chemotherapy drug has been used to treat
various types of cancers including childhood medullo-
blastoma (Jakacki et al. 2012; Kim et al. 2012; Shulman
et al. 2012). It causes crosslinking of DNA, which leads to
tumour cell apoptosis (Tanida et al. 2012). Here DAOY
cells derived from childhood medulloblastoma show
greater sensitivity to cisplatin treatment than PFSK-1 cells.
Cellular nuclear fragmentation of treated DAOY cells was
observed as a sign of DNA damage.
LD accumulation is a common feature frequently
observed in tumour cells (Delikatny et al. 2002) and tissues
(Opstad et al. 2008) undergoing apoptosis and necrosis.
DAOY and PFSK-1 are both primitive neuroectodermal
tumour cell lines possessing a similar number and size of
LDs without treatment. LDs accumulate in DAOY cells
undergoing apoptosis and LDs up to 1.67 lm in diameter
were detected after 48 h cisplatin treatment. No obvious
increase in LD size was observed in PFSK-1 cells with
intact nuclei (Fig. 6). The increase of unsaturated fatty
acids (UFAs) detected by 1H NMR in treated DAOY cells
was not observed in PFSK-1 cells. These observations
imply that UFAs accumulate in LDs in response to treat-
ment. We observed greater number of small LDs in DAOY
cells at 12 h of cisplatin exposure, but this increase was not
large enough to result in increase in 1H NMR detected
lipids in HR-MAS spectra most likely due to the fact that
increase in overall volume of NMR detectable lipids was
below the limit of detection. At later stages of apoptosis
large LDs appear, possibly reflecting shunting of lipids
released through lysosomal processing of lipids from
damaged cell membranes and organelles (Delikatny et al.
2002). A recent study by Boren and Brindle on lymphoma
cells treated with etoposide showed that b-oxidation
becomes inhibited early on in apoptosis leading to
increased de novo synthesis of lipids and accumulation of
LDs. Among UFAs, PUFAs are thought to be naturally
occurring anti-cancer agents (Cockbain et al. 2012). In
human glioma, PUFA may stimulate tumour regression and
apoptosis (Scheim 2009) and has been introduced to cancer
therapy (Bakshi et al. 2003). It is not known yet whether
any of these lipid-based approaches to cancer therapy will
show selectivity for malignant cells, but PUFA supple-
mentation may potentiate some anti-cancer treatment
strategies (Burns and Spector 1994). Enrichment with
PUFAs makes cancer cells more susceptible to lipid per-
oxidation and more sensitive to drug treatment (Burns and
Spector 1994). In addition, the immune response in cancer
can be improved by manipulating the lipid levels in den-
dritic cells (Herber et al. 2010). Therefore, accumulated
PUFAs after cisplatin exposure may not only be end
products of cell collapse but they may also serve as func-
tional lipid mediators actively involved in the cell death
pathway.
5 Concluding remarks
HR-MRS of whole DAOY cells detects an increase in
lipids and the proportion of these lipids which are unsat-
urated during treatment with cisplatin. These changes are
associated with an increase in the number of cytoplasmic
LDs and these droplets contain a greater proportion of
unsaturated lipids than in untreated cells. An increase in the
proportion of unsaturated fatty acids is not seen in the
lipids extracted from whole cells during treatment. Our
data argue that it is pivotal to pay attention to the degree of
lipid unsaturation when considering 1H MRS in monitoring
treatment response.
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